Héloïse retweeted
An assistant professor position is opening at the @institut_thorax. Great science, great environment and amazing colleague ! come to join us !
📢[JOB ALERT] Assistant Professor position in pathophysiology of cardiovascular & metabolic diseases
✅ you are: highly motivated, creative, boast 3+ years experience in CV research
💝Permanent position
🗓️Apply by April 10th '24
⏩Join us by Sept '25!
👉bit.ly/3OyugBm
New paper published recently 🎉
Imaging Cerebral Arteries Tortuosity and Velocities by Transcranial Doppler Ultrasound Is a Reliable Assessment of Brain Aneurysm in Mouse Models ahajournals.org/doi/10.1161/…
@Team6LVTSINSERM
Héloïse retweeted
Dans le cadre du projet Groundstroke financé par @RegionNormandie le laboratoire @ViviensLab1 en collaboration avec @LoopDeeScience recrute un(e) IE pour 3 ans place-emploi-public.gouv.fr/… @BbCaen @Cyceron14 @InsermNordOuest @Inserm
Héloïse retweeted
Very excited to share a new story from @kipnislab led by @Drieu_Antoine in collaboration with many others from within&outside our lab on parenchymal border macrophages (PBMs) in regulation of CSF flow with implications to aging and Alzheimer's disease || nature.com/articles/s41586-0…
Héloïse retweeted
Out today and freely available, a tool many in the image analysis community have been waiting for!
PyImageJ: A library for integrating ImageJ and Python
@EliceiriK @UWMadisonLOCI @ctrueden @CiminiLab @DrAnneCarpenter
nature.com/articles/s41592-0…
Héloïse retweeted
Good job Héloïse Lebas and Clémence Maupu on your poster presentation at the IVBM2022 in Oakland, CA #IVBM2022 . Keep up the good work !
Héloïse retweeted
In a new paper in Nature, scientists looked at candidates for reversing dysregulated gene expression in Alzheimer's disease and guess what outperformed all tested drugs? Exercise.
Why isn't this front page news?
Héloïse retweeted
PN-1 is a glycoprotein that inhibits thrombin and other proteases in the plasminergic system, but how can we measure it?
@Team6LVTSINSERM and colleagues developed a NOVEL lab assay to do just that! #RPTHMethods onlinelibrary.wiley.com/doi/…
Héloïse retweeted
Thrilled to share our latest work in @ScienceAdvances. We have developped #ImmunoMRI method using #biodegradable & ultrasensitive microprobes #M3P, which allows immune diseases follow-up #IBD, #stroke, #MS...Thanks 🫶🏻 to funders & collaborators ⚫️🩻🧠science.org/doi/10.1126/scia…
Great pleasure to announce that our work "PAI-1 production by reactive astrocytes drives tissue dysfibrinolysis in multiple sclerosis models" is now available!
Many thanks to all co-authors link.springer.com/article/10…
@ViviensLab1
@BbCaen
@fabian_docagne
@BoulayAC @CohenSalmonMar2
Héloïse retweeted
Congrats Estelle Louet, Ph.D, Martina Glavan for your work. Thank you Cyrille Orset for the supervision and Denis Vivien for the collaboration on this project !
bb@c, Blood and Brain Caen normandie; Inserm
#collaboration #preclinicalresearch lnkd.in/dCHVwgJd
Héloïse retweeted
Submission for the 3rd ISFP & PA conference in Caen are open cyceron.fr/isfp/ ➡️ Come and register, and spread the information!! @isth @kimpy79 @nikmutch @caterinacasari @DrZeZheng @InsermU1176 @JTHjournal @PatriciaLiaw @cecile_denis
Héloïse retweeted
Reduced number of ICH & mortality among patients treated with glenzocimab (anti-GPVI ACT017) !
📃 PRESS RELEASE 📃
@ActicorBiotech announces positive results from its ACTIMIS phase 1b/2a study in patients with Acute Ischemic Stroke! 🧠
👉 Press release : uploads-ssl.webflow.com/60ed…
#pressrelease #biotech #stroke #ACTIMIS #positiveresults
Héloïse retweeted
Very excited to share our new story on the "missing link" for brain's immunity || Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma science.sciencemag.org/conte…
Héloïse retweeted
Happy to share our new paper led by @st_heindl in @JExpMed: Why is Natalizumab not effective in the chronic phase after stroke? Because T cells proliferate chronically in the brain and evade the targeting by peripheral drugs! tinyurl.com/58njpw3b



















